Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (231-240 of 572) with videos related to

Pageof 58
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplificationEric Angevin, Gianluca Spitaleri, Jordi Rodon, et al.
Iscience|May 30, 2023
Genetically proxied impaired GIPR signaling and risk of 6 cancersMiranda Rogers, Dipender Gill, Emma Ahlqvist, et al.
Epidemiology (Cambridge, Mass.)|July 9, 2020
Association Between Outdoor Light-at-night Exposure and Colorectal Cancer in SpainAriadna Garcia-Saenz, Alejandro Sánchez de Miguel, Ana Espinosa, et al.
Medicine|April 21, 2021
Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, SpainVictor Moreno-Torres, Sara de la Fuente, Patricia Mills, et al.
Molecular Cancer Therapeutics|July 7, 2023
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation StudyFunda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, et al.
British Journal of Cancer|October 6, 2020
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumoursDebbie G J Robbrecht, Juanita Lopez, Emiliano Calvo, et al.
Scientific Reports|February 9, 2016
Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposisPilar Mur, Elena Sánchez-Cuartielles, Susanna Aussó, et al.
Scientific Reports|April 21, 2016
Erratum: Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposisPilar Mur, Elena Sánchez-Cuartielles, Susanna Aussó, et al.
Journal of Crohn'S & Colitis|July 21, 2021
Transcriptome-Wide Association Study for Inflammatory Bowel Disease Reveals Novel Candidate Susceptibility Genes in Specific Colon Subsites and Tissue CategoriesVirginia Díez-Obrero, Ferran Moratalla-Navarro, Gemma Ibáñez-Sanz, et al.
Environmental Health Perspectives|March 8, 2023
Long-Term Exposure to Nitrate and Trihalomethanes in Drinking Water and Prostate Cancer: A Multicase-Control Study in Spain (MCC-Spain)Carolina Donat-Vargas, Manolis Kogevinas, Gemma Castaño-Vinyals, et al.
Pageof 58

Showing results (231-240 of 572) with videos related to

Sort By:
Pageof 58
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplificationEric Angevin, Gianluca Spitaleri, Jordi Rodon, et al.
Iscience|May 30, 2023
Genetically proxied impaired GIPR signaling and risk of 6 cancersMiranda Rogers, Dipender Gill, Emma Ahlqvist, et al.
Epidemiology (Cambridge, Mass.)|July 9, 2020
Association Between Outdoor Light-at-night Exposure and Colorectal Cancer in SpainAriadna Garcia-Saenz, Alejandro Sánchez de Miguel, Ana Espinosa, et al.
Medicine|April 21, 2021
Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, SpainVictor Moreno-Torres, Sara de la Fuente, Patricia Mills, et al.
Molecular Cancer Therapeutics|July 7, 2023
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation StudyFunda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, et al.
British Journal of Cancer|October 6, 2020
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumoursDebbie G J Robbrecht, Juanita Lopez, Emiliano Calvo, et al.
Scientific Reports|February 9, 2016
Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposisPilar Mur, Elena Sánchez-Cuartielles, Susanna Aussó, et al.
Scientific Reports|April 21, 2016
Erratum: Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposisPilar Mur, Elena Sánchez-Cuartielles, Susanna Aussó, et al.
Journal of Crohn'S & Colitis|July 21, 2021
Transcriptome-Wide Association Study for Inflammatory Bowel Disease Reveals Novel Candidate Susceptibility Genes in Specific Colon Subsites and Tissue CategoriesVirginia Díez-Obrero, Ferran Moratalla-Navarro, Gemma Ibáñez-Sanz, et al.
Environmental Health Perspectives|March 8, 2023
Long-Term Exposure to Nitrate and Trihalomethanes in Drinking Water and Prostate Cancer: A Multicase-Control Study in Spain (MCC-Spain)Carolina Donat-Vargas, Manolis Kogevinas, Gemma Castaño-Vinyals, et al.
Pageof 58